Maeng H[au] - Search Results

Year	Number of Results
2001	2
2002	3
2003	4
2004	3
2006	4
2007	2
2008	4
2009	9
2010	7
2011	7
2012	9
2013	8
2014	10
2015	8
2016	9
2017	12
2018	15
2019	14
2020	14
2021	13
2022	16
2023	9
2024	1

1

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.

Kwon OC, Song JJ, Yang Y, Kim SH, Kim JY, Seok MJ, Hwang I, Yu JW, Karmacharya J, Maeng HJ, Kim J, Jho EH, Ko SY, Son H, Chang MY, Lee SH. Kwon OC, et al. Among authors: maeng hj. EMBO Mol Med. 2021 Apr 9;13(4):e13076. doi: 10.15252/emmm.202013076. Epub 2021 Mar 1. EMBO Mol Med. 2021. PMID: 33646633 Free PMC article.

2

Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies.

Nguyen TT, Kim JW, Choi HI, Maeng HJ, Koo TS. Nguyen TT, et al. Among authors: maeng hj. Molecules. 2022 Mar 18;27(6):1977. doi: 10.3390/molecules27061977. Molecules. 2022. PMID: 35335338 Free PMC article.

3

Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo.

Park SY, Gurung R, Hwang JH, Kang JH, Jung HJ, Zeb A, Hwang JI, Park SJ, Maeng HJ, Shin D, Oh SH. Park SY, et al. Among authors: maeng hj. Redox Biol. 2023 Aug;64:102783. doi: 10.1016/j.redox.2023.102783. Epub 2023 Jun 15. Redox Biol. 2023. PMID: 37348157 Free PMC article.

4

Strategies for developing and optimizing cancer vaccines.

Maeng HM, Berzofsky JA. Maeng HM, et al. F1000Res. 2019 May 13;8:F1000 Faculty Rev-654. doi: 10.12688/f1000research.18693.1. eCollection 2019. F1000Res. 2019. PMID: 31131086 Free PMC article. Review.

5

Cancer vaccines: translation from mice to human clinical trials.

Maeng H, Terabe M, Berzofsky JA. Maeng H, et al. Curr Opin Immunol. 2018 Apr;51:111-122. doi: 10.1016/j.coi.2018.03.001. Epub 2018 Mar 16. Curr Opin Immunol. 2018. PMID: 29554495 Free PMC article. Review.

6

Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics.

Golino JL, Wang X, Maeng HM, Xie C. Golino JL, et al. Among authors: maeng hm. Cells. 2023 Mar 10;12(6):862. doi: 10.3390/cells12060862. Cells. 2023. PMID: 36980203 Free PMC article. Review.

7

Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs).

Choi HI, Zeb A, Kim MS, Rana I, Khan N, Qureshi OS, Lim CW, Park JS, Gao Z, Maeng HJ, Kim JK. Choi HI, et al. Among authors: maeng hj. J Control Release. 2022 Oct;350:652-667. doi: 10.1016/j.jconrel.2022.08.055. Epub 2022 Sep 7. J Control Release. 2022. PMID: 36063960 Review.

8

Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery.

Duong VA, Nguyen TT, Maeng HJ. Duong VA, et al. Among authors: maeng hj. Pharmaceutics. 2023 Jan 6;15(1):207. doi: 10.3390/pharmaceutics15010207. Pharmaceutics. 2023. PMID: 36678838 Free PMC article. Review.

9

Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery.

Nguyen TT, Maeng HJ. Nguyen TT, et al. Among authors: maeng hj. Pharmaceutics. 2022 Mar 5;14(3):572. doi: 10.3390/pharmaceutics14030572. Pharmaceutics. 2022. PMID: 35335948 Free PMC article. Review.

10

Mitoxantrone-Loaded PEGylated Gold Nanocomplexes for Cancer Therapy.

Yoon JH, Cho HJ, Jin HE, Maeng HJ. Yoon JH, et al. Among authors: maeng hj. J Nanosci Nanotechnol. 2019 Feb 1;19(2):687-690. doi: 10.1166/jnn.2019.15902. J Nanosci Nanotechnol. 2019. PMID: 30360142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year